'Developing a new drug is stumbling in the dark without a map. We are building the GPS'
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
Site référencé:
Haaretz
Haaretz
In victory for Bennett, soldiers' tuition bill passes without Likud vote
23/05/2022
Israel Police appeal controversial Temple Mount ruling
23/05/2022
One man is stitching together Israel's impossible government – for now
23/05/2022
Yemenite Children Affair : In first, boy's grave opened for DNA testing
23/05/2022
In Jerusalem, EU parliament president vows to fight antisemitism
23/05/2022
Building collapse kills 5 people, injures dozens in south Iran
23/05/2022